ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

11,352Medicare Part D Prescriptions Filled, Including Refills

Rank: 51 out of 1269

$609K Total Retail Price of All Prescriptions

Rank: 88 out of 1269

250 Patients Receiving at Least One Drug in Part D
73%Patients 65 Years and Older
79% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Maryland
Lower avg

Schedule Two
Controlled Substances

12% of this provider’s 250 patients filled at least one prescription for a schedule two drug, compared to an average of 7%.

Schedule Three
Controlled Substances

10% of this provider’s 250 patients filled at least one prescription for a schedule three drug, compared to an average of 5%.

Risky Drugs to Seniors

0% of this provider’s 9,959 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

22% of this provider’s prescriptions were for brand-name drugs, compared to an average of 26%.

Prescription Price

$54 was the average price of a prescription from this provider, compared to $69 among peers.

Prescriptions per Patient

45 is the average number of prescriptions (including refills) per patient, compared to an average of 18.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Maryland
LISINOPRIL 447 364 1 1
OMEPRAZOLE 412 405 2 8
LEVOTHYROXINE SODIUM 406 327 3 4
FUROSEMIDE 370 352 4 5
SIMVASTATIN 333 272 5 3
DONEPEZIL HCL 316 316 6 22
GABAPENTIN 290 234 7 17
AMLODIPINE BESYLATE 275 255 8 2
METOPROLOL TARTRATE 271 269 9 6
TRAZODONE HCL 269 237 10 36
NAMENDA 211 211 11 38
MIRTAZAPINE 195 194 12 24
POLYETHYLENE GLYCOL 3350 194 167 13 50
CARBIDOPA-LEVODOPA 172 167 14 78
WARFARIN SODIUM 165 164 15 12
DIVALPROEX SODIUM 163 163 16 54
METFORMIN HCL 134 92 17 9
ATORVASTATIN CALCIUM 134 126 17 7
HYDROCODONE-ACETAMINOPHEN 129 102 S3 19 20
RISPERIDONE 123 120 20 43
RANITIDINE HCL 118 84 21 27
SPIRIVA 107 84 22 64
ALENDRONATE SODIUM 107 74 22 28
KLOR-CON M20 105 87 24 60
SERTRALINE HCL 103 88 25 23
ATENOLOL 103 92 25 14
ADVAIR DISKUS 101 88 27 46
QUETIAPINE FUMARATE 97 91 28 53
NOVOLOG 97 97 28 82
METOPROLOL SUCCINATE 94 79 30 13
CLOPIDOGREL 90 69 31 32
ESCITALOPRAM OXALATE 88 56 32 58
CITALOPRAM HBR 86 80 33 21
TAMSULOSIN HCL 86 86 33 31
POTASSIUM CHLORIDE 83 80 35 26
GLIPIZIDE 73 66 36 37
NYSTATIN 73 71 36 119
TRAMADOL HCL 70 54 38 16
IPRATROPIUM-ALBUTEROL 66 66 39 86
ZOLPIDEM TARTRATE 66 32 39 19
CYMBALTA 65 46 41 70
AMOXICILLIN 61 44 42 129
PLAVIX 60 43 43 47
PRAVASTATIN SODIUM 60 40 43 11
BUSPIRONE HCL 58 45 45 135
CIPROFLOXACIN HCL 57 53 46 66
FAMOTIDINE 56 56 47 85
ISOSORBIDE MONONITRATE ER 55 55 48 63
FLUOXETINE HCL 55 44 48 83
PANTOPRAZOLE SODIUM 54 52 50 18
PREDNISONE 52 36 51 45
LYRICA 52 15 51 92
OLANZAPINE 51 51 53 89
LEVEMIR 51 48 53 201
HYDRALAZINE HCL 51 49 53 48
ALLOPURINOL 51 42 53 49
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on June 28, 2010.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.